These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 24269847)
1. Differential requirement for wild-type Flt3 in leukemia initiation among mouse models of human leukemia. Kamezaki K; Luchsinger LL; Snoeck HW Exp Hematol; 2014 Mar; 42(3):192-203.e1. PubMed ID: 24269847 [TBL] [Abstract][Full Text] [Related]
2. MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment. Stubbs MC; Kim YM; Krivtsov AV; Wright RD; Feng Z; Agarwal J; Kung AL; Armstrong SA Leukemia; 2008 Jan; 22(1):66-77. PubMed ID: 17851551 [TBL] [Abstract][Full Text] [Related]
3. Flt3 does not play a critical role in murine myeloid leukemias induced by MLL fusion genes. Albouhair S; Morgado E; Lavau C PLoS One; 2013; 8(8):e72261. PubMed ID: 23977266 [TBL] [Abstract][Full Text] [Related]
4. Atg5-dependent autophagy contributes to the development of acute myeloid leukemia in an MLL-AF9-driven mouse model. Liu Q; Chen L; Atkinson JM; Claxton DF; Wang HG Cell Death Dis; 2016 Sep; 7(9):e2361. PubMed ID: 27607576 [TBL] [Abstract][Full Text] [Related]
5. Loss of AML1/Runx1 accelerates the development of MLL-ENL leukemia through down-regulation of p19ARF. Nishimoto N; Arai S; Ichikawa M; Nakagawa M; Goyama S; Kumano K; Takahashi T; Kamikubo Y; Imai Y; Kurokawa M Blood; 2011 Sep; 118(9):2541-50. PubMed ID: 21757616 [TBL] [Abstract][Full Text] [Related]
7. Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis. Ono R; Nakajima H; Ozaki K; Kumagai H; Kawashima T; Taki T; Kitamura T; Hayashi Y; Nosaka T J Clin Invest; 2005 Apr; 115(4):919-29. PubMed ID: 15761502 [TBL] [Abstract][Full Text] [Related]
8. Multistep pathogenesis of leukemia via the MLL-AF4 chimeric gene/Flt3 gene tyrosine kinase domain (TKD) mutation-related enhancement of S100A6 expression. Yamaguchi H; Hanawa H; Uchida N; Inamai M; Sawaguchi K; Mitamura Y; Shimada T; Dan K; Inokuchi K Exp Hematol; 2009 Jun; 37(6):701-14. PubMed ID: 19463771 [TBL] [Abstract][Full Text] [Related]
9. Plzf drives MLL-fusion-mediated leukemogenesis specifically in long-term hematopoietic stem cells. Ono R; Masuya M; Nakajima H; Enomoto Y; Miyata E; Nakamura A; Ishii S; Suzuki K; Shibata-Minoshima F; Katayama N; Kitamura T; Nosaka T Blood; 2013 Aug; 122(7):1271-83. PubMed ID: 23838347 [TBL] [Abstract][Full Text] [Related]
10. EVI1 is critical for the pathogenesis of a subset of MLL-AF9-rearranged AMLs. Bindels EM; Havermans M; Lugthart S; Erpelinck C; Wocjtowicz E; Krivtsov AV; Rombouts E; Armstrong SA; Taskesen E; Haanstra JR; Beverloo HB; Döhner H; Hudson WA; Kersey JH; Delwel R; Kumar AR Blood; 2012 Jun; 119(24):5838-49. PubMed ID: 22553314 [TBL] [Abstract][Full Text] [Related]
11. Bahcc1 is critical for the aberrant epigenetic program in a mouse model of MLL-ENL-mediated leukemia. Nakamura A; Masuya M; Shinmei M; Tawara I; Nosaka T; Ono R Blood Adv; 2024 May; 8(9):2193-2206. PubMed ID: 38452334 [TBL] [Abstract][Full Text] [Related]
12. Potent co-operation between the NUP98-NSD1 fusion and the FLT3-ITD mutation in acute myeloid leukemia induction. Thanasopoulou A; Tzankov A; Schwaller J Haematologica; 2014 Sep; 99(9):1465-71. PubMed ID: 24951466 [TBL] [Abstract][Full Text] [Related]
13. IGF signaling contributes to malignant transformation of hematopoietic progenitors by the MLL-AF9 oncoprotein. Jenkins CE; Shevchuk OO; Giambra V; Lam SH; Carboni JM; Gottardis MM; Holzenberger M; Pollak M; Humphries RK; Weng AP Exp Hematol; 2012 Sep; 40(9):715-723.e6. PubMed ID: 22613471 [TBL] [Abstract][Full Text] [Related]
14. Treatment-induced arteriolar revascularization and miR-126 enhancement in bone marrow niche protect leukemic stem cells in AML. Zhang B; Nguyen LXT; Zhao D; Frankhouser DE; Wang H; Hoang DH; Qiao J; Abundis C; Brehove M; Su YL; Feng Y; Stein A; Ghoda L; Dorrance A; Perrotti D; Chen Z; Han A; Pichiorri F; Jin J; Jovanovic-Talisman T; Caligiuri MA; Kuo CJ; Yoshimura A; Li L; Rockne RC; Kortylewski M; Zheng Y; Carlesso N; Kuo YH; Marcucci G J Hematol Oncol; 2021 Aug; 14(1):122. PubMed ID: 34372909 [TBL] [Abstract][Full Text] [Related]
15. Tet1 is not required for myeloid leukemogenesis by MLL-ENL in novel mouse models. Ono R; Masuya M; Inoue N; Shinmei M; Ishii S; Maegawa Y; Maharjan BD; Katayama N; Nosaka T PLoS One; 2021; 16(3):e0248425. PubMed ID: 33705482 [TBL] [Abstract][Full Text] [Related]
16. An insertional mutagenesis screen identifies genes that cooperate with Mll-AF9 in a murine leukemogenesis model. Bergerson RJ; Collier LS; Sarver AL; Been RA; Lugthart S; Diers MD; Zuber J; Rappaport AR; Nixon MJ; Silverstein KA; Fan D; Lamblin AF; Wolff L; Kersey JH; Delwel R; Lowe SW; O'Sullivan MG; Kogan SC; Adams DJ; Largaespada DA Blood; 2012 May; 119(19):4512-23. PubMed ID: 22427200 [TBL] [Abstract][Full Text] [Related]
17. SIRT2 regulates proliferation and chemotherapy response of MLL-ENL-driven acute myeloid leukemia. Hao C; Shao X; Song J; Peng M; Lao Y; Mack R; Zhang L; Wei W; Liu N; Wang T; Wu Y; Feng L; Yin L; Wang S; Sun X; Chen S; Zhang J; Li B Biochem Biophys Res Commun; 2022 Mar; 596():36-42. PubMed ID: 35108652 [TBL] [Abstract][Full Text] [Related]
19. Ets1 Plays a Critical Role in MLL/EB1-Mediated Leukemic Transformation in a Mouse Bone Marrow Transplantation Model. Fu JF; Yen TH; Huang YJ; Shih LY Neoplasia; 2019 May; 21(5):469-481. PubMed ID: 30974389 [TBL] [Abstract][Full Text] [Related]
20. Homing and invasiveness of MLL/ENL leukemic cells is regulated by MEF2C. Schwieger M; Schüler A; Forster M; Engelmann A; Arnold MA; Delwel R; Valk PJ; Löhler J; Slany RK; Olson EN; Stocking C Blood; 2009 Sep; 114(12):2476-88. PubMed ID: 19584403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]